UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The good and the bad collagens of fibrosis – Their role in signaling and organ function

Advanced drug delivery reviews, 2017-11, Vol.121, p.43-56

2017

Volltextzugriff (PDF)

Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer

Cancer cell, 2023-05, Vol.41 (5), p.887-902.e5

2023

Volltextzugriff (PDF)

Aggrecanase degradation of type III collagen is associated with clinical knee pain

Clinical biochemistry, 2018-08, Vol.58, p.37-43

2018

Volltextzugriff (PDF)

Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes

Diabetologia, 2023-01, Vol.66 (1), p.132-146

2023

Volltextzugriff (PDF)

Recombinant ClearColi™-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma

International immunopharmacology, 2024-10, Vol.143 (Pt 2), p.113283, Article 113283

2024

Volltextzugriff (PDF)

Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines

Cancer cell, 2018-04, Vol.33 (4), p.599-605

2018

Volltextzugriff (PDF)

Predicting T cell recognition of MHC class I restricted neoepitopes

Oncoimmunology, 2018-11, Vol.7 (11), p.e1492508-e1492508

2018

Volltextzugriff (PDF)

Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data

Journal of proteome research, 2020-06, Vol.19 (6), p.2304-2315

2020

Volltextzugriff (PDF)

IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

Frontiers in immunology, 2024-04, Vol.15, p.1360281-1360281

2024

Volltextzugriff (PDF)

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy

Frontiers in immunology, 2021-04, Vol.12, p.644637-644637

2021

Volltextzugriff (PDF)

K27M-mutant histone-3 as a novel target for glioma immunotherapy

Oncoimmunology, 2017-05, Vol.6 (7), p.e1328340-e1328340

2017

Volltextzugriff (PDF)

The neoepitope landscape of breast cancer: implications for immunotherapy

BMC cancer, 2019-03, Vol.19 (1), p.200-200, Article 200

2019

Volltextzugriff (PDF)

iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to caspase-mediated cleavage of tau and apoptotic cell death

Molecular and cellular neuroscience, 2024-09, Vol.130, p.103954, Article 103954

2024

Volltextzugriff (PDF)

Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival

Genome medicine, 2020-03, Vol.12 (1), p.33-16, Article 33

2020

Volltextzugriff (PDF)

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes

Frontiers in immunology, 2017-11, Vol.8, p.1566-1566

2017

Volltextzugriff (PDF)

Circular RNAs as a potential source of neoepitopes in cancer

Frontiers in oncology, 2023-04, Vol.13, p.1098523-1098523

2023

Volltextzugriff (PDF)

Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients

Exploration of immunology, 2023-04, Vol.3 (2), p.82-103

2023

Volltextzugriff (PDF)

Corpora Amylacea in the Human Brain Exhibit Neoepitopes of a Carbohydrate Nature

Frontiers in immunology, 2021-06, Vol.12, p.618193-618193

2021

Volltextzugriff (PDF)

optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input Material

Molecular & cellular proteomics, 2024-09, Vol.23 (9), p.100825, Article 100825

2024

Volltextzugriff (PDF)

Cancer vaccines: what's next?

Oncotarget, 2019-06, Vol.10 (40), p.3985-3987

2019

Volltextzugriff (PDF)

Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer

Journal of experimental & clinical cancer research, 2019-08, Vol.38 (1), p.364-364, Article 364

2019

Volltextzugriff (PDF)

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

Frontiers in oncology, 2024-03, Vol.14, p.1367450-1367450

2024

Volltextzugriff (PDF)

Adoptive Immunotherapy beyond CAR T-Cells

Cancers, 2021-02, Vol.13 (4), p.743

2021

Volltextzugriff (PDF)

Immunochemical Detection and Glycosaminoglycan Disaccharide-Based Characterization of Chondroitin Sulfate Proteoglycans

Methods in molecular biology (Clifton, N.J.), 2023, Vol.2619, p.25

2023

Volltextzugriff (PDF)

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy

Expert review of vaccines, 2022-02, Vol.21 (2), p.173-184

2022

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The good and the bad collagens of fibrosis – Their role in signaling and organ function

Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer

Aggrecanase degradation of type III collagen is associated with clinical knee pain

Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes

Recombinant ClearColi™-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma

Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines

Predicting T cell recognition of MHC class I restricted neoepitopes

Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data

IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy

K27M-mutant histone-3 as a novel target for glioma immunotherapy

The neoepitope landscape of breast cancer: implications for immunotherapy

iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to caspase-mediated cleavage of tau and apoptotic cell death

Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes

Circular RNAs as a potential source of neoepitopes in cancer

Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients

Corpora Amylacea in the Human Brain Exhibit Neoepitopes of a Carbohydrate Nature

optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input Material

Cancer vaccines: what's next?

Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

Adoptive Immunotherapy beyond CAR T-Cells

Immunochemical Detection and Glycosaminoglycan Disaccharide-Based Characterization of Chondroitin Sulfate Proteoglycans

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy

Suchergebnisse filtern